Table 5.

Pairwise comparison results from network meta-analysis on myocardial infarction.

Albiglutide

1.17 (0.91–1.52)

1.19 (0.94–1.5)

1.28 (0.98–1.68)

1.16 (0.86–1.56)

1.39 (1.06–1.82)

1.29 (1.02–1.63)

1.15 (0.89–1.47)

1.37 (1.06–1.77)

1.57 (0.94–2.63)

1.33 (1.1–1.62)

0.91 (0.65–1.26)

1.08 (0.72–1.62)

0.85 (0.66–1.1)

Canagliflozin

1.01 (0.82–1.25)

1.09 (0.85–1.4)

0.99 (0.75–1.3)

1.18 (0.92–1.52)

1.1 (0.89–1.36)

0.98 (0.78–1.23)

1.17 (0.92–1.48)

1.34 (0.81–2.22)

1.14 (0.96–1.34)

0.77 (0.56–1.06)

0.92 (0.62–1.36)

0.84 (0.66–1.07)

0.99 (0.8–1.23)

Dapagliflozin

1.08 (0.86–1.36)

0.98 (0.75–1.27)

1.17 (0.92–1.48)

1.09 (0.9–1.31)

0.97 (0.79–1.19)

1.16 (0.93–1.44)

1.32 (0.81–2.18)

1.12 (0.98–1.28)

0.76 (0.56–1.03)

0.91 (0.62–1.33)

0.78 (0.6–1.02)

0.92 (0.71–1.18)

0.93 (0.74–1.17)

Dulaglutide

0.91 (0.68–1.21)

1.08 (0.83–1.41)

1.01 (0.81–1.27)

0.9 (0.7–1.14)

1.07 (0.83–1.38)

1.23 (0.73–2.05)

1.04 (0.86–1.26)

0.71 (0.51–0.98)

0.84 (0.56–1.26)

0.86 (0.64–1.16)

1.01 (0.77–1.34)

1.02 (0.79–1.33)

1.1 (0.83–1.48)

Empagliflozin

1.19 (0.89–1.6)

1.12 (0.86–1.44)

0.99 (0.75–1.3)

1.18 (0.89–1.57)

1.36 (0.81–2.3)

1.15 (0.92–1.44)

0.78 (0.55–1.11)

0.93 (0.61–1.41)

0.72 (0.55–0.95)

0.85 (0.66–1.09)

0.86 (0.68–1.08)

0.92 (0.71–1.21)

0.84 (0.62–1.12)

Ertugliflozin

0.93 (0.74–1.18)

0.83 (0.64–1.06)

0.99 (0.77–1.28)

1.14 (0.68–1.9)

0.96 (0.8–1.16)

0.65 (0.47–0.91)

0.78 (0.52–1.17)

0.77 (0.61–0.98)

0.91 (0.74–1.12)

0.92 (0.76–1.11)

0.99 (0.79–1.24)

0.9 (0.69–1.16)

1.07 (0.85–1.35)

Exenatide

0.89 (0.72–1.08)

1.06 (0.86–1.31)

1.22 (0.74–1.99)

1.03 (0.91–1.17)

0.7 (0.52–0.95)

0.84 (0.57–1.22)

0.87 (0.68–1.12)

1.03 (0.81–1.29)

1.04 (0.84–1.27)

1.12 (0.88–1.43)

1.01 (0.77–1.33)

1.21 (0.94–1.55)

1.13 (0.92–1.38)

Liraglutide

1.2 (0.95–1.51)

1.37 (0.83–2.26)

1.16 (0.99–1.36)

0.79 (0.58–1.08)

0.94 (0.64–1.39)

0.73 (0.56–0.94)

0.86 (0.68–1.08)

0.86 (0.7–1.07)

0.93 (0.72–1.2)

0.84 (0.64–1.12)

1.01 (0.78–1.3)

0.94 (0.76–1.16)

0.84 (0.66–1.05)

Lixisenatide

1.15 (0.69–1.9)

0.97 (0.82–1.15)

0.66 (0.48–0.91)

0.79 (0.53–1.16)

0.64 (0.38–1.07)

0.75 (0.45–1.24)

0.76 (0.46–1.24)

0.81 (0.49–1.36)

0.74 (0.44–1.24)

0.88 (0.53–1.47)

0.82 (0.5–1.34)

0.73 (0.44–1.2)

0.87 (0.53–1.45)

Osemaglutide

0.85 (0.53–1.37)

0.58 (0.33–1)

0.69 (0.38–1.24)

0.75 (0.62–0.91)

0.88 (0.75–1.04)

0.89 (0.78–1.02)

0.96 (0.8–1.16)

0.87 (0.7–1.09)

1.04 (0.86–1.26)

0.97 (0.85–1.1)

0.86 (0.73–1.01)

1.03 (0.87–1.22)

1.18 (0.73–1.9)

Placebo

0.68 (0.52–0.89)

0.81 (0.57–1.16)

1.1 (0.79–1.54)

1.3 (0.94–1.78)

1.31 (0.97–1.77)

1.41 (1.02–1.96)

1.28 (0.9–1.82)

1.53 (1.1–2.12)

1.43 (1.06–1.92)

1.27 (0.92–1.73)

1.52 (1.1–2.08)

1.74 (1–3)

1.47 (1.12–1.93)

Sotagliflozin

1.19 (0.76–1.86)

0.92 (0.62–1.39)

1.09 (0.74–1.61)

1.1 (0.75–1.61)

1.18 (0.79–1.77)

1.07 (0.71–1.64)

1.28 (0.86–1.92)

1.2 (0.82–1.75)

1.06 (0.72–1.57)

1.27 (0.86–1.88)

1.46 (0.81–2.64)

1.23 (0.86–1.76)

0.84 (0.54–1.31)

Ssemaglutide